OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Deborah O T Alawode, Nick C. Fox, Henrik Zetterberg, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 22
Deborah O T Alawode, Nick C. Fox, Henrik Zetterberg, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 22
Showing 22 citing articles:
GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Cells (2023) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 127
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Cells (2023) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 127
Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 46
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 46
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 53
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 53
Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 877-907
Open Access | Times Cited: 18
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 877-907
Open Access | Times Cited: 18
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
Dawn Matthews, Jefferson W. Kinney, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Dawn Matthews, Jefferson W. Kinney, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Cross‐sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease
Madeline Ally, Michael A. Sugarman, Henrik Zetterberg, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 12
Madeline Ally, Michael A. Sugarman, Henrik Zetterberg, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 12
Neurobiological Role and Therapeutic Potential of Exercise-Induced Irisin in Alzheimer's Disease Management
Nandini Ratne, Sakshi Jari, Manasi Tadas, et al.
Ageing Research Reviews (2025), pp. 102687-102687
Closed Access
Nandini Ratne, Sakshi Jari, Manasi Tadas, et al.
Ageing Research Reviews (2025), pp. 102687-102687
Closed Access
A Review of Clinical Biomarker Insights: Advances in Diagnosis and Prognosis of Early Alzheimer
Ramanathan Rajagopalan, S. Hariharan, N.R. Akshaya, et al.
Global Journal of Medical Pharmaceutical and Biomedical Update (2025) Vol. 20, pp. 5-5
Closed Access
Ramanathan Rajagopalan, S. Hariharan, N.R. Akshaya, et al.
Global Journal of Medical Pharmaceutical and Biomedical Update (2025) Vol. 20, pp. 5-5
Closed Access
Nucleoside analogues: N-glycosylation methodologies, synthesis of antiviral and antitumor drugs and potential against drug-resistant bacteria and Alzheimer's disease
Catarina Maria, Amélia P. Rauter
Carbohydrate Research (2023) Vol. 532, pp. 108889-108889
Closed Access | Times Cited: 9
Catarina Maria, Amélia P. Rauter
Carbohydrate Research (2023) Vol. 532, pp. 108889-108889
Closed Access | Times Cited: 9
scaDA: A novel statistical method for differential analysis of single-cell chromatin accessibility sequencing data
Fengdi Zhao, Xin Ma, Bing Yao, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 8, pp. e1011854-e1011854
Open Access | Times Cited: 3
Fengdi Zhao, Xin Ma, Bing Yao, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 8, pp. e1011854-e1011854
Open Access | Times Cited: 3
Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum
Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17361-17361
Open Access | Times Cited: 8
Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17361-17361
Open Access | Times Cited: 8
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
Guido Maria Giuffrè, Davide Quaranta, Emanuele Maria Costantini, et al.
Neurobiology of Disease (2023) Vol. 186, pp. 106267-106267
Open Access | Times Cited: 7
Guido Maria Giuffrè, Davide Quaranta, Emanuele Maria Costantini, et al.
Neurobiology of Disease (2023) Vol. 186, pp. 106267-106267
Open Access | Times Cited: 7
The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment
Yi‐Chou Hou, Ti-I Chueh, Kuo‐Cheng Lu, et al.
Journal of Alzheimer s Disease (2024), pp. 1-13
Closed Access | Times Cited: 2
Yi‐Chou Hou, Ti-I Chueh, Kuo‐Cheng Lu, et al.
Journal of Alzheimer s Disease (2024), pp. 1-13
Closed Access | Times Cited: 2
scaDA: A Novel Statistical Method for Differential Analysis of Single-Cell Chromatin Accessibility Sequencing Data
Fengdi Zhao, Xin Ma, Bing Yao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Fengdi Zhao, Xin Ma, Bing Yao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1
Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort
Davangere P. Devanand, Seonjoo Lee, José A. Luchsinger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 1
Davangere P. Devanand, Seonjoo Lee, José A. Luchsinger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 1
Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV
Enrico Ripamonti, Arvid Edén, Staffan Nilsson, et al.
Journal of Internal Medicine (2022) Vol. 293, Iss. 4, pp. 445-456
Open Access | Times Cited: 7
Enrico Ripamonti, Arvid Edén, Staffan Nilsson, et al.
Journal of Internal Medicine (2022) Vol. 293, Iss. 4, pp. 445-456
Open Access | Times Cited: 7
Ghrelin system in Alzheimer's disease
Jing Tian, Tienju Wang, Heng Du
Current Opinion in Neurobiology (2022) Vol. 78, pp. 102655-102655
Open Access | Times Cited: 7
Jing Tian, Tienju Wang, Heng Du
Current Opinion in Neurobiology (2022) Vol. 78, pp. 102655-102655
Open Access | Times Cited: 7
In silico Study of Secondary Metabolites from the Leaves of Rumex acetosa against Proteins associated with Inflammatory and Alzheimer
Sani Suleiman, Shema Shehu Abdulsalam, Bello Oluwasesan M.
Fudma Records of Chemical Sciences (2024) Vol. 3, Iss. 2, pp. 9-22
Open Access
Sani Suleiman, Shema Shehu Abdulsalam, Bello Oluwasesan M.
Fudma Records of Chemical Sciences (2024) Vol. 3, Iss. 2, pp. 9-22
Open Access
Fluid-based biomarkers in neurodegeneration: Current findings and future directions
Sanja Blagojević, Marija Jeremić, Ivanka Marković
Medicinski podmladak (2024) Vol. 75, Iss. 5, pp. 23-30
Open Access
Sanja Blagojević, Marija Jeremić, Ivanka Marković
Medicinski podmladak (2024) Vol. 75, Iss. 5, pp. 23-30
Open Access
Lecanemab en la enfermedad de Alzheimer: ¿realmente estamos ante un cambio en el pronóstico de la enfermedad?
David A. Pérez-Martínez
Revista de Neurología (2023) Vol. 76, Iss. 06, pp. 185-185
Open Access | Times Cited: 1
David A. Pérez-Martínez
Revista de Neurología (2023) Vol. 76, Iss. 06, pp. 185-185
Open Access | Times Cited: 1
The Therapeutic Potential of HDAC Inhibitors for Dopamine Deficiency in Alzheimer’s Disease: A Research Protocol
Andrew Huynh, Jillian Cruzana, Sushmita Kiri
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2023) Vol. 7, Iss. 8, pp. 1-8
Open Access | Times Cited: 1
Andrew Huynh, Jillian Cruzana, Sushmita Kiri
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2023) Vol. 7, Iss. 8, pp. 1-8
Open Access | Times Cited: 1
Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.
Fakhrossadat Farvadi, Fatemeh Hashemi, Azadeh Amini, et al.
PubMed (2023) Vol. 12, Iss. 2, pp. 172-210
Closed Access | Times Cited: 1
Fakhrossadat Farvadi, Fatemeh Hashemi, Azadeh Amini, et al.
PubMed (2023) Vol. 12, Iss. 2, pp. 172-210
Closed Access | Times Cited: 1
